Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.270
-0.030 (-2.31%)
At close: Oct 2, 2026, 4:00 PM EDT
1.290
+0.020 (1.57%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $92.05 million as of October 2, 2026. Its market cap has decreased by -25.99% in one year.
Market Cap
92.05M
Enterprise Value
58.11M
1-Year Change
-25.99%
Ranking
Category
Stock Price
$1.27
ChartMarket Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $92.05M, a decrease of -81.18%. That is a compound annual growth rate of -26.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 92.05M | 5.00% |
| Dec 31, 2025 | 87.67M | -37.65% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
| Apr 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atara Biotherapeutics | 95.16M |
| Neumora Therapeutics | 93.93M |
| Rallybio | 90.70M |
| Equillium | 89.41M |
| NeurAxis | 89.29M |
| ImmuCell | 88.55M |
| Nutriband | 88.49M |
| Cognition Therapeutics | 87.97M |